Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	89194
Country	Japan

Received	2023-10-25 13:12
Peer-Review Started	2023-10-25 13:13
To Make the First Decision
Return for Revision	2023-11-30 23:20
Revised	2023-12-13 09:35
Second Decision	2024-01-11 02:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-11 05:16
Articles in Press	2024-01-11 05:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-26 08:11
Publish the Manuscript Online	2024-02-02 09:42

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Toshiaki Tsurui, Yuya Hirasawa, Yutaro Kubota, Kiyoshi Yoshimura and Takuya Tsunoda
ORCID	Author(s) ORCID Number Toshiaki Tsurui http://orcid.org/0000-0002-6167-8953 Yutaro Kubota http://orcid.org/0000-0002-2917-8764 Takuya Tsunoda http://orcid.org/0000-0002-6416-8211
Funding Agency and Grant Number
Corresponding Author	Toshiaki Tsurui, MD, Doctor, Department of Medical Oncology, Showa University, No. 1-5-8, Hatanodai, Shinagawa, Tokyo 1428555, Japan. ttsurui.quantum@gmail.com
Key Words	Colorectal neoplasms; Panitumumab; Chemotherapy; Hyperbilirubinemia; Jaundice; Case report
Core Tip	We report the case of a patient with colorectal cancer and severe hyperbilirubinemia who was successfully treated with anti-EGFR antibody monotherapy. As this approach is safe and potentially lifesaving, it should be considered as a treatment option for hyperbilirubinemia due to hepatic metastases when biliary drainage is impossible.
Publish Date	2024-02-02 09:42
Citation	Tsurui T, Hirasawa Y, Kubota Y, Yoshimura K, Tsunoda T. Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report. World J Gastrointest Oncol 2024; 16(2): 557-562
URL	https://www.wjgnet.com/1948-5204/full/v16/i2/557.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i2.557

Full Article (PDF)	WJGO-16-557-with-cover.pdf
Full Article (Word)	WJGO-16-557.docx
CARE Checklist–2016	89194-CARE Checklist (2016).pdf
Manuscript File	89194_Auto_Edited-YJP.docx
Answering Reviewers	89194-Answering reviewers.pdf
Audio Core Tip	89194-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89194-Conflict-of-interest statement.pdf
Copyright License Agreement	89194-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	89194-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	89194-Language certificate.pdf
Peer-review Report	89194-Peer-review(s).pdf
Scientific Misconduct Check	89194-Bing-Lin C-2.png
Scientific Editor Work List	89194-Scientific editor work list.pdf